David Elsbree

Track

Insider profile

Currently holds a position at T2 Biosystems Inc

Positions

Position Company Period
Independent Director T2 Biosystems Inc July 1, 2014 -
David Elsbree's trades of T2 Biosystems Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
427.54
Quantity 19,923 -5.7%
Value US$1,839,746
Transaction date
Proposed sale
Price
297.68
Quantity 65,332
Value US$3,652,694
Transaction date
Planned sale
Price
355.41
Quantity 5,575 +13.9%
Value US$2,986,632
Transaction date
Planned sale
Price
1.44
Quantity 3,600 -4.2%
Value US$5,184
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-17 2024-09-13
S Sale
19,923 -5.7%
427.54
US$1,839,746 		19,923 -5.7% 427.54 US$1,839,746
2024-09-13 2024-09-13
PrS Proposed sale
65,332
297.68
US$3,652,694 		65,332 297.68 US$3,652,694
2020-01-07 2020-01-03
PlS Planned sale
5,575 +13.9%
355.41
US$2,986,632 		5,575 +13.9% 355.41 US$2,986,632
2019-06-13 2019-06-11
PlS Planned sale
3,600 -4.2%
1.44
US$5,184 		3,600 -4.2% 1.44 US$5,184